Schizophrenia/Psychosis

We’ve been waiting since 1953, the year chlorpromazine was introduced to the US as a revolutionary treatment for schizophrenia, for an active treatment for tardive dyskinesia that the FDA judged to be effective.

How does a pituitary result in a psychiatric emergency? Read more clues to this clinical puzzle.

Despite increasing awareness of the cardiovascular risks, adequate treatment of the metabolic syndrome remains a persistent challenge.

Monitoring patients for 5 key changes can help avert drug toxicity.

Here: common misconceptions about assisted outpatient treatment--and how this tool can help selected mentally ill patients who are most difficult to treat.

Functional remediation therapy addresses the cognitive problems of the nearly 50% of patients who remain impaired even when euthymic.

Marijuana-related problems fall well within the scope of psychiatric practice: many patients use marijuana, which is likely to affect their psychiatric symptoms and response to treatment.

Which patients are at greatest risk for premature death following discharge?

Renewed interest and emerging systematic data have highlighted the frequency and pattern of catatonic presentations in psychiatric and medical settings, including in critical illness.

The results of a phase 3 trial demonstrated significant benefit over placebo.

A psychiatrist's chess game with his patient didn't go the way he expected.

The therapist "goes underwater" with the patient to find what lies in her mind.

Recent findings suggest metabolic abnormalities may be independent of the effects of antipsychotics.

What’s the optimal approach for patients with treatment-resistant schizophrenia?

The Psychiatric Transition Program at the Naval Medical Center in San Diego is a specialized first-episode psychosis program that provides coordinated specialty care to active-duty service members with serious mental illness.

During the past 5 years, new insights into the pathophysiological processes that underlie schizophrenia have been revealed. Here's a quick update.

Can dietary supplementation decrease the risk of transition to psychosis?

To augment or not to augment? That is the question.

The nightmarish reality of psychosis is vividly detailed by Deborah Danner, a woman with self-described schizophrenia, recently shot to death by a New York City policeman.

Are antipsychotics associated with an increased risk of breast cancer?

A recent meta-analysis shows this agent is useful in the prevention and treatment of antipsychotic-induced weight gain.

A “high-tech” approach to relapse prevention in patients with schizophrenia.

Can't keep up with the literature? Here's some help.

With antipsychotics, my once-brilliant child can again speak, write, read, and maintain hygiene and has regained motor functioning.

A recent meta-analysis shows this adjunctive agent reduces residual symptoms of psychopathology as well as body weight.

The year 2016 marks a critical time in our understanding of and approaches to treating schizophrenia spectrum disorders.

Is inflammation a cause or consequence of illness in schizophrenia?

The supposed “epidemic” of mental illness turns out to be mostly a myth in the US adult population, 2000-2015.

What an exciting time to be involved in understanding and providing care for people with schizophrenia spectrum disorders!

Psychiatrists who treat patients with psychosis in institutional, community, and crisis settings provide evaluations and medication management, but rarely consider psychotherapeutic interventions. However, such interventions can be critical in recovery.